Ordering portal updates give customers more features
In our ongoing effort to enhance our customers’ experience, SCA Pharma has responded to feedback and made several changes to the customer portal. Here are recent updates: On the home page, customers will find previously published communications, providing easy access…
SCA Pharma extends Beyond Use Dating on many products
SCA Pharma’s customers have requested extended Beyond Use Dating (BUD), and we are pleased to help meet their needs by extending BUDs on 69 products to date, while still maintaining our stringent quality controls. We anticipate extending BUDs on most…
SCA Pharmaceuticals Appoints Joe Akers as Chief Operating Officer
The indirect costs of risk management for hospital insourcing
This post is our third in a series of blogs looking at how hospitals make the difficult decision to compound their own drugs versus selecting an outsourcing partner. The decision involves a great deal more than a clean room and…
SCA Pharmaceuticals Appoints Chief Commercial Officer
WINDSOR, CONN. (Jan. 28, 2021)– SCA Pharmaceuticals, LLC, announced details last week of their acquisition by The Vistria Group and Excellere. Continuing their strategic growth initiatives, SCA Pharma is announcing the appointment of Mr. Scott Luce as Chief Commercial Officer. …
The Vistria Group and Excellere Capital Management Invest in SCA Pharmaceuticals
WINDSOR, CONN. (Jan. 21, 2021) – SCA Pharmaceuticals, LLC (“SCA Pharma”), has entered into a definitive membership interest purchase agreement with The Vistria Group (“Vistria”) and Excellere Partners (“Excellere”). The Vistria Group and Excellere Partners have purchased all of the…
Thinking of compounding in-house? Don’t forget to calculate these three “hidden” costs.
SCA Pharma is taking a look at how hospitals choose to supply their compounded drug products. Many choose to produce what they need internally – called insourcing – while others use a provider like us – outsourcing. This second blog…
SCA Pharma unveils new virtual tour at HCP fall conference
SCA Pharma just wrapped up the Health Connect Partners (HCP) Hospital Pharmacy fall virtual conference, where we shared a new virtual tour of the SCA Pharma facilities. The tour highlights the steps throughout the product journey, from receiving materials to…
Insourcing versus Outsourcing – the indirect costs of insourcing
Hospitals often choose to insource drug compounding in order to save money on Pharmacy costs. The decision to insource is typically based on a number of factors including cost of raw materials and qualified personnel needed to compound the product.…